Compare DuPont de Nemours Inc (DD) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs Health Care Select Sector SPDR Fund — how do they compare? DuPont de Nemours Inc trades at $144.26 (market cap $19.51B), while Health Care Select Sector SPDR Fund trades at $167.58. The key difference: DuPont de Nemours Inc pays a 1.66% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, DuPont de Nemours Inc nearer its low. Which is the better fit depends on your goals.
| DD | XLV | |
|---|---|---|
Market Cap | $19.51B | — |
Sector | Basic Materials | — |
52-Week High | $154.59 | $168.44 |
52-Week Low | $90.24 | $131.16 |
Enterprise Value | $20.90B | — |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
